Stefano Masi
Associate Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Stefano Masi is an Associate Professor at Università degli Studi di Pisa, Italy. His research focuses on cardiovascular health, including the treatment of periodontitis and its effects on carotid intima-media thickness, as well as the management of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors. He has also contributed to advancements in telemonitoring systems for chronic heart failure and the stratification of cardiovascular risk among various patient populations.
Articles (19)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
The emergence of the highly contagious coronavirus disease has led to multiple pandemic waves, resulting in a significant number of hospitalizations and fatalities. Even outside of hospitals, general practitioners have faced serious challenges, stretching their resources and putting themselves at risk of infection. Telemonitoring systems based on Internet of things technology have emerged as valuable tools for remotely monitoring disease progression, facilitating rapid intervention, and reducing the risk of hospitalization and mortality. They allow for personalized monitoring strategies and tailored treatment plans, which are crucial for improving health outcomes. However, determining the appropriate monitoring intensity remains the responsibility of physicians, which poses challenges and impacts their workload, and thus, can hinder timely responses. To address these challenges, this paper proposes an expert system designed to recommend and adjust the monitoring intensity for COVID-19 patients receiving home treatment based on their medical history, vital signs, and reported symptoms. The system underwent initial validation using real-world cases, demonstrating a favorable performance (F1-score of 0.85). Subsequently, once integrated with an Internet of Things telemonitoring system, a clinical trial will assess the system’s reliability in creating telemonitoring plans comparable with those of medics, evaluate its effectiveness in reducing medic–patient interactions or hospitalizations, and gauge patient satisfaction and safety.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2020
Year:
2020
Collaborators (18)
Gianpaolo Reboldi
Professor of Nephrology
Università degli Studi di Napoli Federico II
Nicola Riccardo Pugliese
University of Pisa
Alessandro Mengozzi
Assistant Professor
University of Pisa
Francesca Viazzi
University of Genova
ROSARIO CIANCI
Professore Associato di Nefrologia
Sapienza University of Rome
Mattia Albiero
Assistant Professor
University of Padova
Stefano Taddei
University of Pisa
Paolo Palatini
University of Padova
Maria Lorenza Muiesan
University of Brescia
Gianfranco Parati
Senior Professor of Cardiovascular Medicine, past Director of the School of Specialization in Cardiovascular Diseases
University of Milano-Bicocca
Luca Fanucci
Professor
University of Pisa
Agostino Virdis
Full Professor of Internal Medicine
University of Pisa
Francesco Paneni
University of Zurich
Florian A. Wenzl
University of Zurich
Massimo Cirillo
Professore ordinario di Nefrologia
Università degli Studi di Napoli Federico II
Massimo Salvetti
Professor
University of Brescia
Andrea Grillo
University of Trieste
PIETRO Cirillo
University of Bari Aldo Moro
Make your next move.
Prepare your application
Review drafts before you send them.